LGL cells and LGL leukemias
Large granular lymphocytes (LGL) represent a morphologically distinct lymphoid subset accounting for about 10-15% of normal peripheral blood mononuclear cells. 1 The cells are relatively large lymphocytes and their cytoplasm contains an abundance of azurophilic granules, hence the designation LGL. 2 Two types of LGLs can be differentiated based on their immunophenotypic and functional features: (1) CD3
+ LGLs which represent activated cytotoxic T lymphocytes (CTL); and (2) CD3
− natural killer (NK)
LGLs. In 1977, a syndrome of increased numbers of circulating
LGLs associated with chronic neutropenia was recognized as a distinct clinical entity. 3 In 1985, the term 'LGL leukemia' was first coined for a clonal disorder involving T-LGLs. 4 In 1989, the French-American-British (FAB) classification proposed to list this disorder as one of four 'chronic (mature) T cell leukemias', however under the designation 'T-CLL (chronic lymphocytic leukemia)'. 5 With additional immunophenotyping and functional data on these unique leukemia cases becoming available, LGL leukemias were further subclassified into T-LGL leukemia and NK-LGL leukemia in 1993. 6 Finally, in 1994 the Revised European-American Classification of Lymphoid Neoplasms (REAL) adopted this classification and recommended the distinction of a T cell and NK cell type of LGL leukemia. 7 The cells are identified by their distinctive morphology and unique immunoprofile. The T cell type of LGL leukemia represents 85% of the LGL leukemias whereas the LGL proliferation of NK cell phenotype account for 15%. 1 The clinical, hematological, morphological, immunological, genetic and biological features, and the differential diagnosis, treatment, and prognosis of T-LGL have been reviewed extensively elsewhere. 1, [6] [7] [8] 
NK cells and NK cell malignancies
Normal NK cells NK cells were first described as a functional subset of lymphocytes based on their cytotoxic activity. 9, 10 Later, they were identified as a third lineage of non-T non-B-lymphocytes.
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NK cells are defined on the basis of morphological, immunophenotypic, genotypic, and functional criteria.
(1) Morphologically, NK cells are LGL. 12 However, only 60-80% of LGLs exhibit NK activity or characteristic NK cell surface antigens; some NK cells may not demonstrate typical LGL morphology. 10 (2) Immunophenotypically, NK cells do not express typical T cell-associated antigens such as CD1, surface CD3 (sCD3), CD4, CD5, CD8ß, CD25, T cell receptors (TCR ␣, ␤, ␥, ␦) nor antigens associated with B cells or myelomonocytic cells. They are positive for CD2, cytoplasmic (cy) CD3⑀, cyCD3, CD7, CD8␣ (partly), CD16, CD56, CD57; CD16 and CD56 are predominantly, but not exclusively expressed in NK cells; cyCD3⑀ is expressed upon activation. 10, 11, 13 (3) Genetically, TCR and immunoglobulin heavy chain (IGH) genes of NK cells are in germline configuration.
14 (4) Functionally, NK cells mediate major histocompatibility complex (MHC)-unrestricted antibody-independent cytolytic reactions ('NK activity') and antibody-dependent cellular cytotoxicity (ADCC). 10 NK cells originate in the bone marrow from a common T cell/NK cell progenitor. 11, 13 Prior to TCR rearrangements, this bipotential common progenitor then differentiates into committed T cell and NK cell progenitors. Immature NK cells can be discerned from their mature progeny according to their immunomarker repertoire and lack of cytotoxic activity. The development of most, if not all NK cells is thymus-independent. 13, 15 Four cytokines seem to be particularly relevant in NK cell biology: interleukins (IL)-2, -12, -15, and -18 (IL-12 was initially termed 'NK cell stimulatory factor'). These molecules play pivotal roles in the development, survival, growth and function of NK cells. [16] [17] [18] [19] 
NK cell malignancies
LGL proliferative disorders are more heterogenous than the initial, rather simple distinction of T-LGL and NK LGL leukemias had suggested. Recently proposed classification schemes illustrate the complexities inherent in the differential diagnosis of NK cell and NK-like T cell malignancies 20, 21 (Table 1) . Here, immature (precursor) NK cell disorders are discerned from mature NK cell malignancies and from NK-like T cell proliferation. The cases of myeloid/NK cell precursor acute leukemia were classified as AML FAB M0 and were assumed to be different from another NK cell-related entity of myeloid/NK cell acute leukemia with mature promyelocytoid morphology. 21, 22 The entity nasal NK cell lymphoma is termed angiocentric lymphoma in the REAL classification. 7 It is obvious that granular lymphocyte morphology and CD56 positivity alone do not have NK cell lineage or NK cell disease specificity as phenotypically and genotypically true T cell disorders may also be positive for these markers. Furthermore, the immature (precursor) NK cell malignancies appear to be negative for azurophilic granules and cytotoxic activity (Table 1) . Thus, the diagnosis seems to rest on the positive identification of NK cell-associated parameters at the exclusion of T cell-associated features (in particular sCD3 
Mature NK cell malignancies Nasal and nasal-like NK cell lymphoma CD2
NK-like T cell malignancies Aggressive T-LGL leukemia/lymphoma (NK-like sCD3 LGL, large granular lymphocyte; LMP, latent membrane protein; LN, lymph node; n.a., not available; NHL, non-Hodgkin's lymphoma; M, male; NK, natural killer; PB, peripheral blood; PF, pericardial fluid; R, at relapse; T, terminal (refractory); T-ALL, T cell ALL; TCR, T cell receptor; T-NHL, T cell NHL.
expression and rearrangements of the TCR genes). Matters are clearly complicated by the overlapping entity profiles and the rarity of the diseases. Clonality of granular lymphocyte proliferative disorders (GLPD) of T cells is determined by the rearrangement of TCR genes, whereas that of NK cell GLPDs is difficult to prove. Direct demonstration of the monoclonal proliferation of NK cells may be based on chromosomal aberrations, X-linked DNA analysis, or the analysis of the structure of Epstein-Barr virus (EBV) termini. 15 Polyclonal expansion is detected in the indolent (chronic, reactive-type) NK lymphocytosis.
Chromosomal abnormalities are commonly found in these tumors. While no constant cytogenetic abnormalities have been identified so far in NK cell malignancies, aberrations involving chromosome 6q appear to be the most frequent. 23 Of note is the association of the mature types of NK cell malignancies with EBV. 24 In particular, the nasal lymphomas are almost uniformly positive for the EBV genome. 15 In contrast, the immature (precursor) NK cell malignancies were described as EBV-negative in all cases.
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NK leukemia-lymphoma cell lines
At first glance, it appears that quite a large panel of NK cell lines have been established over recent years (Tables 2, 3 ). However, a closer review of these cell lines shows that the majority of them do not qualify as true NK leukemialymphoma cell lines (Table 3) .
Uncharacterized, non-immortalized, non-malignant, non-NK, and false cell lines
The immortalization of several early 'cell lines' which, in addition, were unnamed remains questionable; 50,51 these 'cell lines' have not appeared again in the literature since then. It should be noted here that is fairly easy to culture purified NK cells continuously for up to 6 months in the presence of IL-2, without, however, having immortalized the cells which ultimately will die off. In addition, in the past the term 'cell line' has often been used indiscriminately instead of 'cell culture', eg for cells which are growing in culture. A more appropriate designation would be 'continuous cell line' (synonyms: Leukemia immortalized, permanent). 52 The addition of the descriptive adjectives appears to be necessary to differentiate cultured cells with an unlimited number of cell doublings from cultured cells with a limited lifespan.
Other cell lines were only published in abstract form (cell lines EP and VP) and are thus not well characterized and it is not known whether they are truly immortalized. 34 Cell line NK3.3 seems to be a normal non-malignant NK cell line. 37 
Leukemia
The EBV + cell line, KAI3, was derived from a child with a non-neoplastic disease; while the cell line carries a neoplastic karyotype, these cytogenetic alterations were not found in the primary cells. 35 Cell line KH-143 was reported to be derived from a patient with myeloid/NK cell acute leukemia; here, further characterization and proof of immortalization and authentication is required. 36 We found that the three cell lines, NOI-90, SPI-801 and SPI-802, which were reported to be derived from an NK cell lymphoma and T acute lymphoblastic leukemia (T-ALL), respectively, are in reality cross-contaminated cell lines: namely NOI-90 is the precursor B-ALLderived cell line Reh and the SPI-801/802 cell lines are cell line K-562. 42, 43 Cell line TKS-1 stopped growing and was therefore not immortalized (Ref. 
Bona fide NK leukemia-lymphoma cell lines
Six bona fide malignant NK cell lines have been reported (Table 2 ). All six cell lines were established from adults; four cell lines were derived from the peripheral blood, and one each from lymph nodes and pericardial fluid; one cell line was established in 1983, the other five lines between 1992 and 1997. While the diagnosis of the patient from which YT was derived was given only as acute lymphoblastic lymphoma with thymoma, 30 the five other cases were afflicted with an NK cell malignancy: two nasal NK cell lymphomas (cell lines HANK1, NK-YS), one aggressive NK cell leukemia (KHYG-1), one not further defined NK-LGL leukemia (NKL), and one not further defined LGL lymphoma (NK-92). [25] [26] [27] [28] [29] Five of the six cell lines are constitutively IL-2-dependent. With regard to the cellular morphology of these cell lines, in comparison with other types of hematopoietic cell lines, these cells are (as the acronym LGL implies) medium to large size with an abundant, slightly basophilic cytoplasm which contains azurophilic granules; the azurophilic granules may be coarse or fine; nucleoli are not particularly prominent. Unfortunately, only three out of the six cell lines are authenticated; their derivation from the alleged patient was proven by EBV Southern blotting, cytogenetics, and identical p53 point mutation. 53 A detailed description of these cell lines is given in Ref. 54 .
A synopsis of the salient immunophenotypic, genetic and functional features of these NK cell lines is presented in Table 4 . Immunophenotypically, with few exceptions these six cell lines are summarily CD1 
Conclusions
With the availability of specific monoclonal antibodies, appropriate growth factors and adequate culture systems, appreciation of the events surrounding NK cell development and activation is definitely growing. However, NK cells comprise only 10-15% of peripheral blood lymphocytes. 10, 55 Thus, contamination of the purified NK cell fractions by non-NK effector cells is a concern in experimental studies. Clonal populations of NK cells (like NK cell lines) have the obvious advantage of being free of all other cell types. In addition, continuous cell lines provide unlimited amounts of identical cell material. Very few true neoplastic NK cell lines have been established. However, the six cell lines reviewed here appear to represent faithful replicas of the actual in vivo malignant NK cells. Based on the data which are available on already established cell lines, NK leukemia-lymphoma cell lines can now be identified as a discrete subset of malignant lymphocytic cell lines with characteristic morphologic, immunophenotypic, and functional attributes (Table 5 ). Continuous NK cell lines are immunophenotypically quite homogenous and, thus, do not appear to reflect the complexity and diversity of the subentity spectrum of NK cell malignancies. The most important points seem to be an in vitro preservation of NK cell-typical immunoprofiles and of cytotoxic functions. Taken together, the establishment of malignant NK cell lines presents unique opportunities to study normal and neoplastic NK cell biology.
